Related Experiment Video
Updated: Oct 7, 2025

Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
Buprenorphine: a treatment and cause of opioid-induced respiratory depression
Albert Dahan1, Maarten van Lemmen1, Simone Jansen1
1Department of Anesthesiology, Anesthesia & Pain Research Unit, Leiden University Medical Center, Leiden, the Netherlands.
Abstract:
Buprenorphine is a partial agonist at the mu opioid receptor. Due to its relatively low maximum effect on respiratory depression it is considered by some to be a safe opioid. But it can produce serious respiratory depression, particularly when combined with sedatives such as benzodiazepines.
More Related Videos
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
CNS Depressants: Barbiturates and Benzodiazepines
Acute Respiratory Failure-III
Analgesia and Pain Management

